Director, Bioscience
ImpriMed, Inc.
Mountain View, California, United States
Ilona Holcomb is a molecular biotechnologist with over two decades of experience in academia and cancer research. She specializes in genomic instability in breast and prostate cancers and earned her Ph.D. in Molecular Biotechnology from the University of Washington, focusing on prostate cancer. At Stanford University, she continued as a Postdoctoral Fellow in Cancer Biology, investigating basal-like breast cancer. Known for her collaborative approach, Ilona integrates Next Generation Sequencing (NGS) to explore key questions in cancer biology. Her commitment reflects a passion for advancing cancer treatment strategies and diagnostic techniques.
Disclosure information not submitted.